Xiaorong Lv

Xiaorong Lv

Auto-generated profile, based on publicly available information

Xiaorong Lv


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2025 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
XLXiaorong Lv
Xiaorong Lv
NWNan Wang
Nan Wang
CZChi Zhang
Chi Zhang
RZRan Zheng
Ran Zheng
YZYuanqing Zhang
Yuanqing Zhang
FNFang Nie
Fang Nie

1 March 2026 in Clinical Hemorheology and Microcirculation
Verified
Journal Article
Closed access
GCGuo Chen
Guo Chen
YWYanfang Wang
Yanfang Wang
GWGuojuan Wang
Guojuan Wang
RYRong Yang
Rong Yang
RZRan Zheng
Ran Zheng
FNFang Nie
Fang Nie
Objective: Partially cystic thyroid nodules (PCTNs) are frequently underestimated in clinical practice and managed conservatively, potentially increasing the risk of cervical lymph node metastasis. This study aims to explore the contrast-enhanced ultrasound features associated with malignancy in PCTNs. Methods: This retrospective study included 94 PCTNs from 87 patients in the Second Hospital of Lanzhou University between January 2019 and December 2024. Conventional ultrasound, contrast-enhanced ultrasound (CEUS) features, and clinical data of the nodules were analyzed. Using pathological diagnosis as the gold standard, univariate and multivariate logistic regression analyses were conducted to identify independent predictors of malignancy in PCTNs. A predictive model was subsequently developed, and its diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis. Results: Centrifugal perfusion, an ill-defined enhancement boundary, faster washout, and the absence of a peripheral high-enhancement ring are independent predictors of malignant PCTNs. The resulting predictive model exhibited excellent diagnostic performance for PCTNs, with a sensitivity of 92.7%, a specificity of 92.5%, a Youden index of 0.852, and an AUC of 0.968. Conclusions: CEUS features are valuable in differentiating malignant nodules from benign PCTNs, improving physicians’ diagnostic confidence in distinguishing benign and malignant PCTNs, and assisting clinicians in clinical decision-making.

16 March 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
YZYuanqing Zhang
Yuanqing Zhang
YHYang He
Yang He
YCYifei Chen
Yifei Chen
XLXiaorong Lv
Xiaorong Lv
RYRong Yang
Rong Yang
FNFang Nie
Fang Nie
Objective: The objective of this study was to develop and validate a predictive model for MTM-HCC by integrating preoperative ultrasound (US) and contrast-enhanced ultrasound (CEUS) features with relevant clinical characteristics. Methods: This retrospective study analyzed data from patients with histopathologically confirmed hepatocellular carcinoma who underwent preoperative CEUS examination at the Ultrasound Department of the Lanzhou University Second Hospital between December 2021 and March 2025. The study cohort comprised 45 patients diagnosed with MTM-HCC and 194 patients with non-MTM-HCC. Ultrasound and CEUS images were independently reviewed by two senior abdominal radiologists with extensive experience in hepatic imaging, ensuring objective feature assessment. Clinical variables and imaging characteristics were systematically compared between the two groups to identify distinguishing patterns. To evaluate the associations among clinical data, ultrasound-derived features, and MTM-HCC, univariate analyses were first performed, followed by multivariate logistic regression to construct and assess predictive models. Results: A total of 239 patients (mean age: 57.28 ± 9.60 years; 187 males and 52 females) were included in the analysis. Among them, 45 HCC patients (18.8%) were classified as MTM-HCC. Multivariate analysis identified four independent predictors: elevated alpha-fetoprotein (AFP ≥ 467 ng/mL) (OR = 8.5, 95% CI: 4.2–17.30; p < 0.001), presence of non-enhancing necrotic areas (OR = 5.92, 95% CI: 1.82–19.30, p = 0.003), intratumoral arteries (OR = 6.61, 95% CI: 2.28–19.22, p < 0.001), and peritumoral feeding arteries (OR = 3.13, 95% CI: 1.15–8.50, p = 0.025). Conclusions: An integrated prediction model that combines ultrasound imaging and clinical parameters offers a feasible, non-invasive approach for accurate preoperative identification of MTM-HCC.